Allogeneic CAR-engineered cellular therapy for relapsed and refractory large B cell lymphoma: a systematic review and meta-analysis.
Saved in:
| Title: | Allogeneic CAR-engineered cellular therapy for relapsed and refractory large B cell lymphoma: a systematic review and meta-analysis. |
|---|---|
| Authors: | Biederstädt A; Department of Medicine III, Technical University of Munich (TUM), School of Medicine and Health, Munich, Germany.; TranslaTUM, Center for Translational Cancer Research, Technical University of Munich (TUM), Munich, Germany., Bassermann F; Department of Medicine III, Technical University of Munich (TUM), School of Medicine and Health, Munich, Germany.; TranslaTUM, Center for Translational Cancer Research, Technical University of Munich (TUM), Munich, Germany.; Deutsches Konsortium für Translationale Krebsforschung (DKTK), Heidelberg, Germany.; Bavarian Cancer Research Center (BZKF), Munich, Germany., Hecker JS; Department of Medicine III, Technical University of Munich (TUM), School of Medicine and Health, Munich, Germany.; TranslaTUM, Center for Translational Cancer Research, Technical University of Munich (TUM), Munich, Germany.; Bavarian Cancer Research Center (BZKF), Munich, Germany. |
| Source: | Frontiers in immunology [Front Immunol] 2025 Jul 08; Vol. 16, pp. 1585556. Date of Electronic Publication: 2025 Jul 08 (Print Publication: 2025). |
| Publication Type: | Journal Article; Systematic Review; Meta-Analysis |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1664-3224 |
|---|---|
| DOI: | 10.3389/fimmu.2025.1585556 |
